Entasis: Entasis Therapeutics : Termination of a Material Definitive Agreement - Form 8-K

(marketscreener.com) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 ...https://www.marketscreener.com/quote/stock/ENTASIS-THERAPEUTICS-HOLD-46353304/news/Entasis-Therapeutics-Termination-of-a-Material-Definitive-Agreement-Form-8-K-40957583/?utm_medium=RSS&utm_content=20220711